Literature DB >> 11063489

Evaluation of six immunoassays for detection of dengue virus-specific immunoglobulin M and G antibodies.

J Groen1, P Koraka, J Velzing, C Copra, A D Osterhaus.   

Abstract

The performance of six commercially available immunoassay systems for the detection of dengue virus-specific immunoglobulin M (IgM) and IgG antibodies in serum was evaluated. These included two IgM and IgG enzyme immunoassays (EIA) from MRL Laboratories and PanBio, a rapid immunochromatographic test (RIT) from PanBio, immunofluorescence assays (IFA) from Progen, a dot blot assay from Genelabs, and a dipstick EIA from Integrated Diagnostics (INDX). For this study a panel of 132 serum samples, including 90 serum samples from patients with suspected dengue virus infection and 42 serum samples from patients with other viral infections, was used. In addition, serial serum samples from two monkeys experimentally immunized and challenged with dengue virus type 2 were used. Results were considered conclusive when concordant results were obtained with four of the six antibody-specific assays. Based on this definition, the calculated overall agreement for the human serum samples for the respective IgM immunoassays was 97% (128 of 132), with 34% (45 of 132) positive serum samples, 63% (83 of 132) negative samples, and 3% of samples (4 of 132) showing discordant results. The calculated overall agreement for the IgG assays was 94% (124 of 132), with 49% (65 of 132) positive, 45% (59 of 132) negative, and 6% (8 of 132) discordant results, respectively. The sensitivities of the dengue virus-specific assays evaluated varied between 71 and 100% for IgM and between 52 and 100% for IgG, with specificities of 86 to 96% and 81 to 100%, respectively. The relative sensitivities of the respective IgM assays measured with the monkey serum samples were comparable with those obtained with 12 serial serum samples from humans. Overall performance, based on the sum of the agreement, sensitivity, specificity, and Kappa statistics of the IgM and IgG immunoassays, showed that the antibody detection systems from INDX and Genelabs and the MRL and PanBio EIA are useful and reliable assays for dengue virus serodiagnosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063489      PMCID: PMC95976          DOI: 10.1128/CDLI.7.6.867-871.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  12 in total

1.  Evaluation of the MRL diagnostics dengue fever virus IgM capture ELISA and the PanBio Rapid Immunochromatographic Test for diagnosis of dengue fever in Jamaica.

Authors:  C J Palmer; S D King; R R Cuadrado; E Perez; M Baum; A L Ager
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Evaluation of a dipstick enzyme-linked immunosorbent assay for detection of antibodies to dengue virus.

Authors:  S J Wu; B Hanson; H Paxton; A Nisalak; D W Vaughn; C Rossi; E A Henchal; K R Porter; D M Watts; C G Hayes
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

3.  Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses.

Authors:  D H CLARKE; J CASALS
Journal:  Am J Trop Med Hyg       Date:  1958-09       Impact factor: 2.345

4.  An evaluation of nine commercial EIA kits for the detection of measles specific IgG.

Authors:  L Hesketh; A Charlett; P Farrington; E Miller; T Forsey; P Morgan-Capner
Journal:  J Virol Methods       Date:  1997-06       Impact factor: 2.014

5.  Multicentre evaluation of dengue IgM dot enzyme immunoassay.

Authors:  S K Lam; M Y Fong; E Chungue; S Doraisingham; A Igarashi; M A Khin; Z T Kyaw; A Nisalak; C Roche; D W Vaughn; V Vorndam
Journal:  Clin Diagn Virol       Date:  1996-11

6.  The micro-focus reduction neutralization test for determining dengue and Japanese encephalitis neutralizing antibodies in volunteers vaccinated against dengue.

Authors:  N Jirakanjanakit; T Sanohsomneing; S Yoksan; N Bhamarapravati
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Sep-Oct       Impact factor: 2.184

7.  Induction of protective immunity against Dengue virus type 2: comparison of candidate live attenuated and recombinant vaccines.

Authors:  J Velzing; J Groen; M T Drouet; G van Amerongen; C Copra; A D Osterhaus; V Deubel
Journal:  Vaccine       Date:  1999-03-17       Impact factor: 3.641

Review 8.  Dengue and dengue hemorrhagic fever.

Authors:  E B Hayes; D J Gubler
Journal:  Pediatr Infect Dis J       Date:  1992-04       Impact factor: 2.129

9.  Evaluation of capture ELISA and rapid immunochromatographic test for the determination of IgM and IgG antibodies produced during dengue infection.

Authors:  S K Lam; P L Devine
Journal:  Clin Diagn Virol       Date:  1998-05-01

10.  Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells.

Authors:  C Delenda; M P Frenkiel; V Deubel
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more
  51 in total

1.  Severe dengue virus infection in pediatric travelers visiting friends and relatives after travel to the Caribbean.

Authors:  Nivedita Krishnan; Murli Purswani; Stefan Hagmann
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections.

Authors:  Pei-Yun Shu; Li-Kuang Chen; Shu-Fen Chang; Yi-Yun Yueh; Ling Chow; Li-Jung Chien; Chuan Chin; Ting-Hsiang Lin; Jyh-Hsiung Huang
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

Review 3.  Current advances in dengue diagnosis.

Authors:  Pei-Yun Shu; Jyh-Hsiung Huang
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

4.  Single antigen detects both immunoglobulin M (IgM) and IgG antibodies elicited by all four dengue virus serotypes.

Authors:  Menaka D Hapugoda; Gaurav Batra; W Abeyewickreme; S Swaminathan; N Khanna
Journal:  Clin Vaccine Immunol       Date:  2007-09-26

5.  Evaluation of two rapid immunochromatographic assays for diagnosis of dengue among Vietnamese febrile patients.

Authors:  Tran Thi Thanh Nga; Khoa T D Thai; Hoang Lan Phuong; Phan Trong Giao; Le Quoc Hung; Tran Quang Binh; Vo Thi Chi Mai; Nguyen Van Nam; Peter J de Vries
Journal:  Clin Vaccine Immunol       Date:  2007-04-25

6.  Recombinant polypeptide antigen-based immunoglobulin G enzyme-linked immunosorbent assay for serodiagnosis of dengue.

Authors:  Flavia B Dos Santos; Rita Maria R Nogueira; Monique R Q Lima; Thatiane S De Simone; Hermann G Schatzmayr; Elezer M B Lemes; Eva Harris; Marize P Miagostovich
Journal:  Clin Vaccine Immunol       Date:  2007-03-28

7.  Utility of IgM/IgG ratio and IgG avidity for distinguishing primary and secondary dengue virus infections using sera collected more than 30 days after disease onset.

Authors:  Harry E Prince; Cindy Yeh; Mary Lapé-Nixon
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

8.  Multicountry prospective clinical evaluation of two enzyme-linked immunosorbent assays and two rapid diagnostic tests for diagnosing dengue fever.

Authors:  Subhamoy Pal; Allison L Dauner; Andrea Valks; Brett M Forshey; Kanya C Long; Butsaya Thaisomboonsuk; Gloria Sierra; Victor Picos; Sara Talmage; Amy C Morrison; Eric S Halsey; Guillermo Comach; Chadwick Yasuda; Michael Loeffelholz; Richard G Jarman; Stefan Fernandez; Ung Sam An; Tadeusz J Kochel; Louis E Jasper; Shuenn-Jue L Wu
Journal:  J Clin Microbiol       Date:  2015-01-14       Impact factor: 5.948

9.  Dengue virus immunoglobulin M detection in a reference laboratory setting during the 2010 dengue virus outbreak on Caribbean islands.

Authors:  Harry E Prince; Jose L Matud; Jay M Lieberman
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

10.  Seroepidemiology of Dengue virus in Mayotte, Indian Ocean, 2006.

Authors:  Daouda Sissoko; Khaled Ezzedine; Claude Giry; Amrat Moendandzé; Tinne Lernout; Eric D'Ortenzio; François Pettinelli; Denis Malvy
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.